Document:

<PAGE>

                                                                     EXHIBIT 4.7

THIS DEBENTURE, AND THE SECURITIES INTO WHICH IT IS CONVERTIBLE (COLLECTIVELY,
THE "SECURITIES"), HAVE NOT BEEN REGISTERED WITH THE UNITED STATES SECURITIES
AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THE
SECURITIES ARE BEING OFFERED PURSUANT TO A SAFE HARBOR FROM REGISTRATION UNDER
REGULATION S PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
"ACT"). THE SECURITIES ARE "RESTRICTED" AND MAY NOT BE OFFERED OR SOLD IN THE
UNITED STATES OR TO U.S. PERSONS (AS SUCH TERM IS DEFINED IN REGULATION S
PROMULGATED UNDER THE ACT) UNLESS THE SECURITIES ARE REGISTERED UNDER THE ACT,
PURSUANT TO REGULATION S OR PURSUANT TO AVAILABLE EXEMPTIONS FROM THE
REGISTRATION REQUIREMENTS OF THE ACT AND THE SELLER WILL BE PROVIDED WITH
OPINION OF COUNSEL OR OTHER SUCH INFORMATION AS IT MAY REASONABLY REQUIRE TO
CONFIRM THAT SUCH EXEMPTIONS ARE AVAILABLE. FURTHER HEDGING TRANSACTIONS
INVOLVING THE SECURITIES MAY NOT BE MADE EXCEPT IN COMPLIANCE WITH THE ACT.

                                    DEBENTURE

                                JAGNOTES.COM INC.

                          2000 8% Convertible Debenture

                             Due ____________, 2003

No. A-___                                                          $500,000

         This Debenture is issued by JagNotes.com Inc., (the "Company") to CALP
II Limited Partnership, a limited partnership organized under the laws of
Bermuda (together with its successors and assigns, the "Holder") pursuant to
exemptions from registration under the U.S. Securities Act of 1933, as amended.

                                    ARTICLE I

         1.01    Principal and Interest. For value received, on __________, 2003
(the "Maturity Date"), the Company hereby promises to pay to the order of the
Holder, at the offices of Thomson Kernaghan & Co. Limited, 365 Bay Street, Tenth
Floor, Toronto, Ontario M5H2V2, Canada, in lawful money of the United States of
America and in immediately available fund the principal sum of $500,000 together
with interest on the unpaid principal of this Debenture at the

                                       1

<PAGE>

rate of 8% per year (computed on the basis of a 365 day year and the actual days
elapsed) from the date of this Debenture until paid.

         1.02.   Conversion. The Holder is entitled, at its option, to convert
at any time and from time to time, until payment in full of this Debenture, all
or any part of the principal amount of the Debenture, plus accrued interest,
into shares (the "Conversion Shares") of the Company's common stock, $0.00001
par value ("Common Stock"), at the price per share (the "Conversion Price")
equal to the lesser of (i) $0.80 and (ii) 75% of the average of the five (5)
lowest closing bid prices of the Common Stock on the Principal Market quoted by
Bloomberg L.P. (the "Closing Bid Price") during the 20 trading days immediately
preceding the Conversion Date (the "Conversion Price"). As used herein,
"Principal Market" shall mean the Nasdaq Bulletin Board System, Nasdaq Small Cap
Market, or American Stock Exchange. If the Common Stock is not traded on a
Principal Market, the Closing Bid Price shall mean, the reported Closing Bid
Price for the Common Stock, as furnished by the National Association of
Securities Dealers, Inc., for the applicable periods. No fraction of shares or
scrip representing fractions of shares will be issued on conversion, but the
number of shares issuable shall be rounded to the nearest whole share. To
convert this Debenture, the holder hereof shall deliver written notice thereof,
substantially in the form of Exhibit A to this Debenture, with appropriate
insertions (the "Conversion Notice"), to the Company at its address set forth
above. The date upon which the conversion shall be effective (the "Conversion
Date") shall be deemed to be the date set forth in the Conversion Notice,
provided that the Company delivers the Conversion Shares within three (3)
business days after receipt of a Conversion Notice, otherwise, the holder shall
have the right to revoke the Conversion Notice, or to specify the date on which
it actually receives the Conversion Shares as the Conversion Date.

         1.03    Reservation of Common Stock. The Company shall reserve and keep
available out of its authorized but unissued shares of Common Stock, solely for
the purpose of effecting the conversion of this Debenture, such number of shares
of Common Stock as shall from time to time be sufficient to effect such
conversion, based upon the Conversion Price. If at any time the Company does not
have a sufficient number of Conversion Shares authorized and available, then the
Company shall call and hold a special meeting of its stockholder within 30 days
of that time for the sole purpose of increasing in the number of authorized
shares of Common Stock.

         1.04    Interest Payments. The interest so payable will be paid at the
time of maturity or conversion to the person in whose name this Debenture is
registered. At the time such interest is payable, the Company, in its sole
discretion, may elect to pay interest in cash (via wire transfer or certified
funds) or in the form of Common Stock. In the event of default, as described in
Article III Section 3.01 hereunder, the Holder, may elect that the interest be
paid in cash (via wire transfer or certified funds) or in the form of Common
Stock. If paid in the form of Common Stock, the amount of stock to be issued
will be calculated as follows: the value of the stock shall be the Closing Bid
Price on: (i) the date the interest payment is due; or (ii) if the interest
payment is not made when due, the date the interest payment is made. A number of
shares of Common Stock with a value equal to the amount of interest due shall be
issued. No fractional shares will be issued; therefore, in the event that the
value of the Common Stock per share does not equal the total interest due, the
Company will pay the balance in cash.

                                       2

<PAGE>

         1.05    Paying Agent and Registrar. Initially, the Company will act as
paying agent and registrar. The Company may change any paying agent, registrar,
or Company-registrar by giving the Holder not less than 10 days' written notice
of its election to do so, specifying the name, address, telephone number and
facsimile number of the Paying Agent or Registrar. The Company may act in any
such capacity.

         1.06    Subordinated Nature of Debenture. This Debenture and all
 payments hereon, including principal or interest, shall be subordinate and
junior in right of payment to all accounts payable of the Company incurred in
the ordinary course of business and or bank debt of the Company not to exceed
 $500,000.

         1.07    Registration Rights. The Holder shall have the right to demand
that the Company register the Conversion Shares by filing a Registration
Statement on Form SB-2 with the Securities and Exchange Commission no later than
December 29, 2000.

                                   ARTICLE II

         2.01    Amendments and Waiver of Default. The Debenture may be amended
with the consent of the Holder. Without the consent of the Holder, the Debenture
may be amended to cure any ambiguity, defect or inconsistency, to provide for
assumption of the Company obligations to the Holder or to make any change that
does not adversely affect the rights of the Holder.

                                   ARTICLE III

         3.01    Events of Default. An Event of Default is defined as follows:
(a) failure by the Company to pay amounts due hereunder within two (2) days of
the Maturity Date; (b) failure by the Company to advise its transfer agent to
issue Common Stock to the Holder within two (2) business days of the Company's
receipt of the attached Notice of Conversion from Holder; (c) failure by the
Company for thirty (30) days after notice to it to comply with any of its other
agreements in the Debenture; (d) events of bankruptcy or insolvency; (e) a
breach by the Company of its obligations under the Letter Agreement, dated as of
October 30, 2000, between the Company and Thomson Kernaghan & Co., Ltd. (the
"Letter Agreement"). The Holder may not enforce the Debenture except as provided
herein.

         3.02    Failure to Issue Unrestricted Common Stock. As indicated in
Article III Section 3.01, a breach by the Company of its obligations under the
Letter Agreement shall be deemed an Event of Default, which if not cured within
ten (10) days, shall entitle the Investor(s) accelerated full repayment of all
debentures outstanding. The Company acknowledges that failure to honor a Notice
of Conversion shall cause hardship to the Investor(s).

                                       3

<PAGE>

                                   ARTICLE IV

         4.01    Rights and Terms of Conversion. This Debenture, in whole or
in part, may be converted at any time following the date of closing, into shares
of Common Stock at a price equal to the Conversion Price.

         4.02    Mandatory Conversion. Provided that a Registration Statement
is then in effect for the Conversion Shares and the Company is not then in
default under this Debenture or the Letter Agreement, and subject to the
limitations contained in paragraph 4.05 of this Debenture, the Company shall
have the right to require the Holder to convert unpaid principal of and accrued
interest on this Debenture, by giving the Holder not less than 5 days' prior
written notice of the amount to be converted, up to the maximum amount in any
consecutive 15 day period based upon the average Closing Bid Price and the
average daily trading volume during the 20 trading days preceding the date of
such notice, as set forth in the table below, less the amounts thereof
voluntarily converted during such 30 day period:

<TABLE>
<CAPTION>

                             20-Day Avg.        20-Day Avg.          20-Day Avg.       20-Day Avg.           20-Day Avg.
                                Daily               Daily              Daily              Daily                  Daily
                           Trading Volume      Trading Volume      Trading Volume      Trading Volume        Trading Volume
                           ---------------     ---------------     ----------------    ----------------      --------------
   Avg. Closing
     Bid Price              30,000-49,999       50,000-99,999      100,000-149,999     150,000-199,999        200,000-Above
                           ---------------     ---------------     ----------------    ----------------      --------------
<S>                       <C>                 <C>                 <C>                 <C>                   <C>
   $1.00-$1.49                  $30,000            $ 75,000             $150,000            $225,000              $300,000
   $1.50-$1.99                  $45,000            $112,500             $225,000            $337,500              $450,000
   $2.00-$2.49                  $60,000            $150,000             $300,000            $450,000              $600,000
   $2.50-$2.99                  $75,000            $187,500             $375,000            $562,500              $750,000
   $3.00-Above                  $90,000            $225,000             $450,000            $675,000              $900,000

</TABLE>

         4.03    Reissuance of Debenture. When the Holder elects to convert a
part of the Debenture, then the Company shall reissue a new Debenture in the
same form as this Debenture to reflect the new principal amount.

         4.04    Termination of Conversion Rights. The Holder's right to
convert the Debenture into the Common Stock in accordance with paragraph 4.01
shall terminate on _________, 2003 shall be automatically converted on that date
in accordance with the formula set forth in Section 4.01 hereof, and the
appropriate shares of common stock and amount of interest shall be issued to the
Holder.

         4.05    Limitation on Right and Power to Exercise. Any provision in
this Debenture or any other document to the contrary not withstanding, the
Holder shall not have the right or power to convert this Debenture into Common
Stock, either in whole or in part, and any attempt to do

                                       4

<PAGE>

so shall be void, if, after having given effect to such conversion, the Holder
shall be or shall be deemed to be the beneficial owner of 10% or more of the
then outstanding Common Stock within the meaning or for the purposes of Section
13(d) or 13(g) of the U.S. Securities Exchange Act of 1934, as amended, or as
the term "beneficial owner" is defined in Rule 13d-3 of the U.S. Securities and
Exchange Commission or otherwise.

                                    ARTICLE V

         5.01    Antidilution. In case the Company shall at any time
subdivide the outstanding shares of Common Stock, or shall issue a stock
dividend on the outstanding Common Stock, the conversion price in effect
immediately prior to such subdivision or the issuance of such dividend shall be
proportionately decreased, and in case the Company shall at any time combine the
outstanding shares of Common Stock, the conversion price in effect immediately
prior to such combination shall be proportionately increased, effective at the
close of business on the date of such subdivision, dividend or combination as
the case may be.

                 So long as any of the principal of or interest on this
Debenture remains unpaid and unconverted, the Company shall not, without the
prior consent of the holder, issue or sell (i) any Common Stock without
consideration or for a consideration per share less than its fair market value
determined immediately prior to its issuance, or (ii) issue or sell any warrant,
option, right, contract, call, or other security or instrument granting the
holder thereof the right to acquire Common Stock without consideration or for a
consideration per share less than such Common Stock's fair market value
determined immediately prior to its issuance.

                                   ARTICLE VI

         6.01    Notice. Notices regarding this Debenture shall be sent to
the parties at the following addresses, unless a party notifies the other
parties, in writing, of a change of address:

                  If to the Company:       JAGNOTES.COM INC.
                                           226 West 26th Street
                                           Studio D
                                           New York, New York 10001
                                           Attention: President

                  If to Holder:            CALP II Limited Partnership
                                           c/o Thomson Kernaghan & Co., Ltd.
                                           365 Bay Street 10th Floor
                                           Toronto, Ontario M5H2V2

         6.02    Governing Law. This Debenture shall be deemed to be made
under and shall be construed in accordance with the laws of the State of New
York without giving effect to the

                                       5

<PAGE>

principals of conflict of laws thereof. Each of the parties consents to the
jurisdiction of the U.S. District Court sitting in the Southern District of the
State of New York or the state courts of the State of New York sitting in
Manhattan in connection with any dispute arising under this Debenture and hereby
waives, to the maximum extent permitted by law, any objection, including any
objection based on forum non conveniens to the bringing of any such proceeding
in such jurisdictions.

         6.03    Severability. The invalidity of any of the provisions of this
Debenture shall not invalidate or otherwise affect any of the other provisions
of this Debenture, which shall remain in full force and effect.

         6.04    Entire Agreement and Amendments. This Debenture represents the
entire agreement between the parties hereto with respect to the subject matter
hereof and there are no representations, warranties or commitments, except as
set forth herein. This Debenture may be amended only by an instrument in writing
executed by the parties hereto.

         6.05    Counterparts. This Debenture may be executed in multiple
counterparts, each of which shall be an original, but all of which shall be
deemed to constitute on instrument.

         IN WITNESS WHEREOF, with the intent to be legally bound hereby, the
Company as executed this Debenture as of this ____ day of _______________, 2000.

                                         JAGNOTES.COM INC.

                                         By:______________________________
                                            Name:  Thomas J. Mazzarisi
                                            Title: Executive Vice President &
                                                   General Counsel

                                       6

<PAGE>

                                   EXHIBIT "A"

                              NOTICE OF CONVERSION

        (To be executed by the Holder in order to Convert the Debenture)

TO: JAGNOTES.COM

         The undersigned hereby irrevocably elects to convert $________________
of the principal amount of the above Debenture into Shares of Common Stock of
JagNotes.com Inc., according to the conditions stated therein, as of the
Conversion Date written below.

         Conversion Date_______________________________________

         Applicable Conversion Price ____________________________

         Signature_____________________________________________

         Name________________________________________________

         Address______________________________________________

                                      -7-<PAGE>

                                                                     EXHIBIT 4.8

THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT PURPOSES ONLY AND NOT WITH A VIEW
TOWARD RESALE OR DISTRIBUTION. THIS WARRANT MAY NOT BE OFFERED FOR SALE, SOLD,
TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE
STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL IN FORM, SUBSTANCE AND SCOPE
REASONABLY ACCEPTABLE TO THE ISSUER THAT REGISTRATION IS NOT REQUIRED UNDER SAID
ACT.

                                JAGNOTES.COM INC.

                        WARRANT TO PURCHASE COMMON STOCK

Warrant No.: 13                           Number of Shares Issuable: 3,000,000
Date of Issuance: October 30, 2000

         JagNotes.com Inc., a Nevada corporation (the "Company"), hereby
certifies that, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, CALP II LIMITED PARTNERSHIP, the registered
holder hereof or his permitted assigns, is entitled, subject to the terms set
forth below, to purchase from the Company upon surrender of this Warrant, at any
time or times on or after the date hereof, but not after 5:00 P.M. Eastern
Standard Time on the Expiration Date (as defined herein) THREE MILLION
(3,000,000) fully paid nonassessable shares of Common Stock (as defined herein)
of the Company (the "Warrant Shares") at the Warrant Exercise Price per share
provided in Section l(a) below;

         Section 1.

         (a) Letter Agreement. This Warrant is being issued pursuant to the
terms of the Letter Agreement, dated as of October 30, 2000, by and between the
Company and Thomson Kernaghan & Co., Ltd.

         (b) Definitions. The following words and terms as used in this Warrant
shall have the following meanings:

         (i) "Common Stock" means (i) the Company's common stock, par value
$0.0001 per share, and (ii) any capital stock into which such Common Stock shall
have been changed or any capital stock resulting from a reclassification of such
Common Stock.

         (ii) "Convertible Securities" means any stock or securities (other than
Options) directly or indirectly convertible into or exchangeable for Common
Stock.

                                       1

<PAGE>

         (iii) "Expiration Date" means the date five (5) years from the date of
the issuance of the Warrant or, if such date falls on a Saturday, Sunday or
other day on which banks are required or authorized to be closed in the City of
New York or the State of New York (a "Holiday"), the next preceding date that is
not a Holiday.

         (iv) "Options" means any rights, warrants or options to subscribe for
or purchase Common Stock or Convertible Securities.

         (v) "Other Securities" means other Warrants.

         (vi) "Person" means an individual, a limited liability company, a
partnership, a joint venture, a corporation, a trust, an unincorporated
organization and a government or any department or agency thereof.

         (vii) "Principal Market" means the Nasdaq Bulletin Board System, Nasdaq
Small-Cap Market, or American Stock Exchange.

         (viii)   "Securities Act" means the Securities Act of 1933, as amended.

         (ix) "Warrant" shall mean this warrant and all warrants issued in
exchange, transfer or replacement of any thereof.

         (x) "Warrants" shall mean this Warrant together with the warrants
issued, or issuable, to CALP II Limited Partnership pursuant to the terms and
conditions of the Equity Line of Credit Agreement, dated as of June 14, 2000, by
and between the Company and CALP II Limited Partnership, as may be amended from
time to time.

         (x) "Warrant Exercise Price" shall be equal to $1.25, subject to
adjustment as hereinafter provided.

         (b) Other Definitional Provisions.

                  (i) Except as otherwise specified herein, all references
         herein (A) to the Company shall be deemed to include the Company's
         successors and (B) to any applicable law defined or referred to herein,
         shall be deemed references to such applicable law as the same may have
         been or may be amended or supplemented from time to time.

                  (ii) When used in this Warrant, the words "herein," "hereof,"
         and "hereunder," and words of similar import, shall refer to this
         Warrant as a whole and not to any provision of this Warrant, and the
         words "Section," "Schedule," and "Exhibit" shall refer to Sections of,
         and Schedules and Exhibits to, this Warrant unless otherwise specified.

                  (iii) Whenever the context so requires, the neuter gender
         includes the masculine or feminine, and the singular number includes
         the plural, and vice versa.

                                       2

<PAGE>

         Section 2.        Exercise of Warrant.

         (a) Subject to the terms and conditions hereof, this Warrant may be
exercised by the holder hereof then registered on the books of the Company, in
whole or in part, at any time on any business day or after the opening of
business on the date hereof and prior to 11:59 P.M. Eastern Standard Time on the
Expiration Date by (i) delivery of a written notice, in the form of the
subscription notice attached as Exhibit A hereto, of such holder's election to
exercise this Warrant, which notice shall specify the number of Warrant Shares
to be purchased, (ii) (A) payment to the Company of an amount equal to the
Warrant Exercise Price multiplied by the number of Warrant Shares as to which
the Warrant is being exercised (plus any applicable issue or transfer taxes)
(the "Aggregate Exercise Price") in cash or by check or wire transfer, or (B) by
notifying the Company that it should subtract from the number of Warrant Shares
issuable to the holder upon such exercise an amount of Warrant Shares having a
last reported sale price (as reported by Bloomberg) or fair market value on the
date immediately preceding the date of the subscription notice equal to the
Aggregate Exercise Price of the Warrant Shares for which this warrant is being
exercised (a "Cashless Exercise"), and (iii) the surrender of this Warrant, to a
common carrier for delivery to the Company as soon as practicable following such
date, this Warrant (or an indemnification undertaking with respect to this
Warrant in the case of its loss, theft, or destruction); provided that if such
Warrant Shares are to be issued in any name other than that of the registered
holder of this Warrant, such issuance shall be deemed a transfer and the
provisions of Section 7 shall be applicable. In the event of any exercise of the
rights represented by this Warrant in compliance with this Section 2, a
certificate or certificates for the Warrant Shares so purchased, in such
denominations as may be requested by the holder hereof and registered in the
name of, or as directed by, the holder, shall be delivered at the Company's
expense to, or as directed by, such holder as soon as practicable after such
rights shall have been so exercised, and in any event no later than five (5)
business days after the Company's receipt of the Exercise Notice, the Aggregate
Exercise Price and this Warrant (or indemnification undertaking with respect to
this Warrant in the case of its loss, theft or destruction) Upon delivery of the
Exercise Notice and Aggregate Exercise Price referred to in clause (ii) (A)
above or notification to the Company of a Cashless Exercise referred to in
clause (ii) (B) above, the holder of this Warrant shall be deemed for all
corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date
of delivery of this Warrant as required by clause (iii) above or the
certificates evidencing such Warrant Shares. In the case of a dispute as to the
determination of the Warrant Exercise Price or the Average Market Price of a
security or the arithmetic calculation of the Warrant Shares, the Company shall
promptly issue to the holder the number of shares of Common Stock that is not
disputed and shall submit the disputed determinations or arithmetic calculations
to the holder via facsimile within five (5) business days of receipt of the
holder's subscription notice. If the holder and the Company are unable to agree
upon the determination of the Warrant Exercise Price or Average Market Price or
arithmetic calculation of the Warrant Shares within five (5) business days of
such disputed determination or arithmetic calculation being submitted to the
holder, then the Company shall immediately submit via facsimile (i) the disputed
determination of the Warrant Exercise Price or the Average Market Price to an
independent, reputable investment banking firm or (ii) the disputed arithmetic
calculation of the Warrant Shares to its independent, outside accountant. The
Company shall cause the investment banking firm or the accountant, as the case
may be, to perform the determinations or calculations and notify the Company and
the holder of the results no later than forty-eight (48) hours from the time it
receives the disputed determinations or calculations. Such investment bank's or
accountant's determination or

                                       3

<PAGE>

calculation, as the case may be, shall be deemed conclusive absent manifest
error and the Company shall be liable for the costs and expenses related to such
determination or calculation.

         (b) Unless the rights represented by this Warrant shall have expired or
shall have been fully exercised, the Company shall, as soon as practicable and
in any event no later than five (5) business days after any exercise and at its
own expense, issue a new Warrant identical in all respects to the Warrant
exercised except (i) it shall represent rights to purchase the number of Warrant
Shares purchasable immediately prior to such exercise under the Warrant
exercised, less the number of Warrant Shares with respect to which such Warrant
is exercised, and (ii) the holder thereof shall be deemed for all corporate
purposes to have become the holder of record of such Warrant Shares immediately
prior to the close of business on the date on which the Warrant is surrendered
and payment of the amount due in respect of such exercise and any applicable
taxes is made, irrespective of the date of delivery of certificates evidencing
such Warrant Shares, except that, if the date of such surrender and payment is a
date when the stock transfer books of the Company are properly closed, such
person shall be deemed to have become the holder of such Warrant Shares at the
opening of business on the next succeeding date on which the stock transfer
books are open. Upon presentation of a duly executed Subscription Form in the
Form of Exhibit A to this Warrant, the holder shall be entitled to exercise this
Warrant in whole or in part, if the holder shall have previously exercised and
surrendered this Warrant and the Company shall not have issued a new Warrant
representing the number of shares issuable following such prior exercise.

         (c) No fractional shares of Common Stock are to be issued upon the
exercise of this Warrant, but rather the number of shares of Common Stock issued
upon exercise of this Warrant shall be rounded up or down to the nearest whole
number.

         (d) If the Company shall fail for any reason or for no reason to issue
to holder on a timely basis as described under this Section 2, a certificate for
the number of shares of Common Stock to which the holder is entitled upon the
holder's exercise of this, the Company shall, in addition to any other remedies
under this Agreement or otherwise available to such holder pay as additional
damages in cash to such holder for each day such issuance is not timely effected
an amount equal to .25% of the product of (A) the sum of the number of shares of
Common Stock not issued to the holder on a timely basis and to which the holder
is entitled, and (B) the sum derived by subtracting (1) the Warrant exercise
price then in effect, from (2) the closing bid price of the Common Stock on the
last possible date which the Company could have issued Common Stock, as the case
may be, to the holder without violating this Section 2.

         (e) The Company shall not effect any exercise of any Warrant and no
holder of any Warrant shall have the right to exercise any Warrant pursuant to
Section 2 to the extent that after giving to such exercise such person (together
with such Persons affiliates) (A) would beneficially owned in excess of 4.9% of
the outstanding shares of Common Stock following such conversion and (B) would
have acquired, through exercise of any Warrant or otherwise, in excess of 4.9%
of the outstanding shares of the Common Stock following such exercise during the
60-day period ending on and including such exercise date; provided, that the
holder of any Warrant shall have the right to exercise such Warrant regardless
of the percent of outstanding shares of Common Stock such holder would own
following the exercise thereof if the holder exercises the Warrant within 60
days prior to the Expiration Date. For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by a person and its
affiliates or acquired by a person and its affiliates, as the case may be, shall
include the

                                       4

<PAGE>

number of shares of Common Stock issuable upon the exercise of the Warrant with
respect to which the determination of such sentence is being made, but shall
exclude the number of shares of Common Stock which would be issuable upon (i)
exercise of the remaining, non exercisable Warrants beneficially owned by such
person and its affiliates and (ii) exercise or conversion of the unexercised or
unconverted portion of any other securities of the Company subject to limitation
on conversion or exercise analogous to the limit contained herein beneficially
owned by such Person and its affiliates. Except as set forth in the preceding
sentence, for purposes of this section 2(e), beneficial ownership shall be
calculated in accordance with Section 13 (d) of the Securities Exchange Act of
1934, as amended. Notwithstanding anything to the contrary contained herein,
each Exercise Notice shall constitute a representation by the holder submitting
such Exercise Notice that, after giving effect to such Exercise Notice (A) the
holder will not beneficially own (as determined in accordance with this Section
2(e)) and (B) during the 60-day period ending on and including such exercise
date, the holder will not have acquired, through exercise of any Warrant or
otherwise, a number of shares of Common Stock in excess of 4.9% of the
outstanding shares of Common Stock as reflected in the Company's most recent
Form 10-QSB or Form 10-KSB, as the case may be, or more recent public release or
other public notice by the Company setting forth the number of Shares of Common
Stock outstanding, but after giving effect to exercise of any Warrant by such
holder since the date as of which such numbers of outstanding shares of the
Common Stock was reported.

         Section 3. Covenants as to Common Stock. The Company hereby covenants
and agrees as follows:

         (a)    This Warrant is, duly authorized and validly issued.

         (b) All Warrant Shares which may be issued upon the exercise of the
rights represented by this Warrant will, upon issuance, be validly issued, fully
paid and nonassessable and free from all taxes, liens and charges with respect
to the issue thereof.

         (c) During the period within which the rights represented by this
Warrant may be exercised, the Company will at all times have authorized and
reserved at least the number of shares of Common Stock needed to provide for the
exercise of the rights then represented by this Warrant and the par value of
said shares will at all times be less than or equal to the applicable Warrant
Exercise Price.

         (d) The Company shall promptly secure the listing of the shares of
Common Stock issuable upon exercise of this Warrant upon each national
securities exchange or automated quotation system, if any, or
over-the-counter-bulletin board upon which shares of Common Stock are then
listed or quoted (subject to official notice of the over-the-counter bulletin
board of issuance upon exercise of this Warrant) and shall maintain, so long as
any other shares of Common Stock shall be so listed or quoted, such listing or
quotation of all shares of Common Stock from time to time issuable upon the
exercise of this Warrant; and the Company shall so list or obtain quotation on
each such national securities exchange, automated quotation system or
over-the-counter bulletin board, as the case may be, and shall maintain such
listing in quotation of, any other shares of capital stock of the Company
issuable upon the exercise of this Warrant if and so long as any shares of the
same class shall be listed on such national securities exchange, automated
quotation system or over-the-counter bulletin board.

                                       5

<PAGE>

         (e) The Company will not, by amendment of its Certificate of
Incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms to be
observed or performed by it hereunder, but will at all times in good faith
assist in the carrying out of all the provisions of this Warrant and in the
taking of all such action as may reasonably be requested by the holder of this
Warrant in order to protect the exercise privilege of the holder of this Warrant
against dilution or other impairment, consistent with the tenor and purpose of
this Warrant. Without limiting the generality of the foregoing, the Company (i)
will not increase the par value of any shares of Common Stock receivable upon
the exercise of this Warrant above the Exercise Price then in effect, and (ii)
will take all such actions as may be necessary or appropriate in order that the
Company may validly and legally issue fully paid and nonassessable shares of
Common Stock upon the exercise of this Warrant.

         (f) This Warrant will be binding upon any entity succeeding to the
Company by merger, consolidation or acquisition of all or substantially all of
the Company's assets.

         (g) If at any time the Company proposes to file with the Securities and
Exchange Commission a registration statement relating to an offering for its own
account or the account of others under the Securities Act of any of its
securities (other than on Form S-4 or Form S-8 (or their equivalents at such
time relating to securities to be issued solely in connection with any
acquisition of any entity or business or equity securities issuable in
connection with stock option or other employee benefit plans) the Company shall
promptly send to the Holder's written notice of the Company's intention to file
a registration statement and of the holder's rights under this section and, if
within five (5) days after receipt of such notice, the holder hereof shall so
request in writing, the Company shall include in such registration statement all
or any part of the Common Stock underlying this Warrant the holder requests to
be registered. If a registration pursuant this section is to be an underwritten
public offering and the managing underwriters advise the Company in writing,
that in their reasonable good faith opinion, marketing or other factors dictate
that a limitation on the number of shares of Company common stock which may be
included in the registration statement is necessary to facilitate and not
adversely affect the proposed offering, then the Company shall include in such
registration : (1) first, all securities the Company proposes to sell for its
own account, (2) second, up to the full number of securities proposed to be
registered for the account of the holders of securities entitled to inclusion of
their securities requested to be registered by the holder hereof and other
holders of securities entitled to participate in the registration, as of the
date hereof, drawn from them pro rata based on the number each has requested to
be included in such registration.

         Section 4. Taxes. The Company shall not be required to pay any tax or
taxes attributable to the initial issuance of the Warrant Shares or any
permitted transfer involved in the issue or delivery of any certificates for
Warrant Shares in a name other than that of the registered holder hereof or upon
any permitted transfer of this Warrant.

         Section 5. Warrant Holder Not Deemed a Stockholder. Except as otherwise
specifically provided herein, no holder, as such, of this Warrant shall be
entitled to vote or receive dividends or be deemed the holder of shares of the
Company for any purpose, nor shall anything contained in this Warrant be
construed to confer upon the holder hereof, as such, any of the rights of a
stockholder of the Company or any right to vote, give or withhold consent to any
corporate action (whether any

                                       6

<PAGE>

reorganization, issue of stock, reclassification of stock, consolidation,
merger, conveyance or otherwise), receive notice of meetings, receive dividends
or subscription rights, or otherwise, prior to the issuance to the holder of
this Warrant of the Warrant Shares which he or she is then entitled to receive
upon the due exercise of this Warrant.

         In addition, nothing contained in this Warrant shall be construed as
imposing any liabilities on such holder to purchase any securities or as a
stockholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company. Notwithstanding this Section 5, the Company will
provide the holder of this Warrant with copies of the same notices and other
information given to the stockholders of the Company generally,
contemporaneously with the giving thereof to the stockholders.

         Section 6. Representations of Holder. The holder of this Warrant, by
the acceptance hereof, represents (and any assignor shall represent) that it is
acquiring this Warrant and the Warrant Shares for its own account for investment
purposes and not with a view to, or for sale in connection with, any
distribution hereof, and not with any present intention of distributing any of
the same. The holder of this Warrant further represents (and any assignor shall
represent), by acceptance hereof, that, as of this date, such holder is an
"accredited investor" as such term is defined in Rule 501(a)(1) of Regulation D
promulgated by the Securities and Exchange Commission under the Securities Act
(an "Accredited Investor"). Upon exercise of this Warrant, the holder shall, if
requested by the Company, confirm in writing, in a form satisfactory to the
Company, that the Warrant Shares so purchased are being acquired solely for the
holder's own account and not as a nominee for any other party, for investment,
and not with a view toward distribution or resale and that such holder is an
Accredited Investor. If such holder cannot make such representations because
they would be factually incorrect, it shall be a condition to such holder's
exercise of the Warrant that the Company receive such other representations as
the Company considers reasonably necessary to assure the Company that the
issuance of its securities upon exercise of the Warrant shall not violate any
United States Federal or state securities laws.

         Section 7. Ownership and Transfer.

         (a) The Company shall maintain at its principal executive offices (or
such other office or agency of the Company as it may designate by notice to the
holder hereof), a register for this Warrant, in which the Company shall record
the name and address of the person in whose name this Warrant has been issued,
as well as the name and address of each permissible transferee. The Company may
treat the person in whose name any Warrant is registered on the register as the
owner and holder thereof for all purposes, notwithstanding any notice to the
contrary, but in all events recognizing any transfers made in accordance with
the terms of this Warrant.

         (b) This Warrant and the rights granted to the holder hereof are
transferable, in whole or in part, upon surrender of this Warrant, together with
a properly executed warrant power in the form of Exhibit B attached hereto;
provided, however, that any transfer or assignment shall subject to the
conditions set forth in Section 6 above and Section 7(c) below.

         (c) The holder of this Warrant understands that this Warrant has not
been and is not expected to be, registered under the Securities Act or any state
securities laws, and may not be offered for sale, sold, assigned or transferred
unless (a) subsequently registered thereunder, or (b) such holder shall have

                                       7

<PAGE>

delivered to the Company an opinion of counsel, reasonably satisfactory in form,
scope and substance to the Company, to the effect that the securities to be
sold, assigned or transferred may be sold, assigned or transferred pursuant to
an exemption from such registration. Any sale of such securities made in
reliance on Rule 144 promulgated under the Securities Act may be made only in
accordance with the terms of said Rule and further, if said Rule is not
applicable, any resale of such securities under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the Securities Act) may require
compliance with some other exemption under the Securities Act or the rules and
regulations of the Securities and Exchange Commission thereunder; and neither
the Company nor any other person is under any obligation to register the Warrant
Shares under the Securities Act or any state securities laws or to comply with
the terms and conditions of any exemption thereunder except as set forth in
Section 7(d) below.

         (d) The Company has agreed to register the Warrant Shares for resale
under the Securities Act on a Registration Statement on Form SB-2 to be filed
with the Securities and Exchange Commission no later than December 29, 2000,
pursuant to the terms and conditions of the Letter Agreement, dated as of
October 30, 2000, between the Company and Thomson Kernaghan & Co., Ltd.

         Section 8. Indemnification.

         (a) (i) Indemnification by the Company. The Company agrees to indemnify
and hold harmless the registered holder hereof, its partners, affiliates,
officers, directors, employees, counsel and duly authorized agents, and each
Person or entity, if any, who controls the holder within the meaning of Section
15 of the Securities Act, or Section 20 of the Securities Exchange Act of 1934,
as amended, together with the partners, affiliates, officers, directors,
employees, counsel and duly authorized agents of such controlling Person or
entity (collectively, the "Controlling Persons"), from and against any loss,
claim, damage, liability, costs and expenses (including, without limitation,
reasonable attorneys' fees and disbursements and costs and expenses of
investigating and defending any such claim) (collectively, "Damages"), joint or
several, and any action or proceeding in respect thereof to which the registered
holder, its partners, affiliates, officers, directors, employees and duly
authorized agents, and any Controlling Person, may become subject under the
Securities Act or otherwise, as incurred, insofar as such Damages (or actions or
proceedings in respect thereof) arise out of, or are based upon, any untrue
statement or alleged untrue statement of a material fact contained in any
registration statement, preliminary prospectus or prospectus relating to the
Warrant Shares or arises out of, or are based upon, any omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances under which they were made, except insofar as any such untrue
statement, alleged untrue statement, omission or alleged omission is made in
reliance upon and in conformity with written information furnished to the
Company by the registered holder which is specifically intended by the
registered holder for use in the preparation of any such registration statement,
preliminary prospectus or prospectus, and shall reimburse the registered holder,
its partners, affiliates, officers, directors, employees, counsel and duly
authorized agents, and each such Controlling Person, for any legal and other
expenses reasonably incurred by the Registered holder, its partners, affiliates,
officers, directors, employees, counsel and duly authorized agents, or any such
Controlling Person, as incurred, in investigating or defending or preparing to
defend against any such Damages or actions or proceedings; provided, however,
that the Company shall not be liable to the registered holder to the extent that
any such Damages arise out of or are based upon an untrue statement or omission
made in any preliminary prospectus if (i) the registered holder failed to

                                       8

<PAGE>

send or deliver a copy of the final prospectus delivered by the Company to the
registered holder with or prior to the delivery of written confirmation of the
sale by the registered holder to the Person asserting the claim from which such
Damages arise, and (ii) the final prospectus would have corrected such untrue
statement or alleged untrue statement or such omission or alleged omission.

             (ii) Indemnification by the Holder. The registered holder hereof
agrees to indemnify and hold harmless the Company, its affiliates, officers,
directors, employees, counsel and duly authorized agents, and each Controlling
Persons of the Company, from and against any and all Damages, joint or several,
and any action or proceeding in respect thereof to which the registered holder,
its partners, affiliates, officers, directors, employees, counsel and duly
authorized agents, and any such Controlling Person, may become subject under the
Securities Act or otherwise, as incurred, insofar as such Damages (or actions or
proceedings in respect thereof) arise out of, or are based upon, any untrue
statement or alleged untrue statement of a material fact contained in any
registration statement, preliminary prospectus or prospectus relating to the
Warrant Shares or arises out of, or are based upon, any omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances under which they were made, but only to the extent that any such
untrue statement, alleged untrue statement, omission or alleged omission is made
in reliance upon and in conformity with written information furnished to the
Company by the registered holder of this Warrant which is specifically intended
by the registered holder for use in the preparation of any such registration
statement, preliminary prospectus or prospectus, and shall reimburse the
Company, its partners, affiliates, officers, directors, employees, counsel and
duly authorized agents, and each such Controlling Person, for any legal and
other expenses reasonably incurred by the registered holder hereof, its
partners, affiliates, officers, directors, employees, counsel and duly
authorized agents, or any such Controlling Person, as incurred, in investigating
or defending or preparing to defend against any such Damages or actions or
proceedings.

         (b) Conduct of Indemnification Proceedings. Promptly after receipt by
any person or entity in respect of which indemnity may be sought pursuant to
Section 8(a) (an "Indemnified Party") of notice of any claim or the commencement
of any action, the Indemnified Party shall, if a claim in respect thereof is to
be made against the person or entity against whom such indemnity may be sought
(the "Indemnifying Party"), notify the Indemnifying Party in writing of the
claim or the commencement of such action. In the event an Indemnified Party
shall fail to give such notice as provided in this Section 8(b) and the
Indemnifying Party to whom notice was not given was unaware of the proceeding to
which such notice would have related and was prejudiced by the failure to give
such notice, the indemnification provided for in Section 8(a) shall be reduced
to the extent of any actual prejudice resulting from such failure to so notify
the Indemnifying Party; provided, however, that the failure to notify the
Indemnifying Party shall not relieve the Indemnifying Party from any liability
that it may have to an Indemnified Party otherwise than under Section 8(a). If
any such claim or action shall be brought against an Indemnified Party, and it
shall notify the Indemnifying Party thereof, the Indemnifying Party shall be
entitled to participate therein, and, to the extent that it wishes, jointly with
any other similarly notified Indemnifying Party, to assume the defense thereof
with counsel reasonably satisfactory to the Indemnified Party. After notice from
the Indemnifying Party to the Indemnified Party of its election to assume the
defense of such claim or action, the Indemnifying Party shall not be liable to
the Indemnified Party for any legal or other expenses subsequently incurred by
the Indemnified Party in connection with the defense thereof other than
reasonable costs of investigation; provided, however, that the Indemnified Party
shall have the right to employ separate counsel to represent the Indemnified
Party and its

                                       9

<PAGE>

Controlling Persons who may be subject to liability arising out of any claim in
respect of which indemnity may be sought by the Indemnified Party against the
Indemnifying Party, but the fees and expenses of such counsel shall be for the
account of such Indemnified Party, unless (i) the Indemnifying Party and the
Indemnified Party shall have mutually agreed to the retention of such counsel or
(ii) in the reasonable judgment of the Indemnifying Party and the Indemnified
Party, representation of both parties by the same counsel would be inappropriate
due to actual or potential conflicts of interest between them, it being
understood, however, that the Indemnifying Party shall not, in connection with
any one such claim or action or separate but substantially similar or related
claims or actions in the same jurisdiction arising out of the same general
allegations or circumstances, be liable for the fees and expenses of more than
one separate firm of attorneys (together with appropriate local counsel) at any
time for all Indemnified Parties, or for fees and expenses that are not
reasonable. No Indemnifying Party shall, without the prior written consent of
the Indemnified Party, effect any settlement of any claim or pending or
threatened proceeding in respect of which the Indemnified Party is or could have
been a party and indemnity is sought hereunder by such Indemnified Party, unless
such settlement includes an unconditional release of such Indemnified Party from
all liability arising out of such claim or proceeding. Whether or not the
defense of any claim or action is assumed by the Indemnifying Party, such
Indemnifying Party will not be subject to any liability for any settlement made
without its consent, which consent will not be unreasonably withheld.

         (c) Other Indemnification. Indemnification similar to that specified in
the preceding paragraphs of this Section 8 (with appropriate modifications)
shall be given by the Company with respect to any required registration or other
qualification of securities under any federal or state law or regulation of any
governmental authority other than the Securities Act. The provisions of this
Section 8 shall be in addition to any other rights to indemnification,
contribution or other remedies which an Indemnified Party may have pursuant to
law, equity, contract or otherwise.

         (d) Contribution. If the indemnification and reimbursement obligations
provided for in any section of this Section 8 is unavailable or insufficient to
hold harmless the Indemnified Parties in respect of any Damages referred to
herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified
Party, shall contribute to the amount paid or payable by such Indemnified Party
as a result of such Damages as between the Company on the one hand and the
registered holder hereof on the other, in such proportion as is appropriate to
reflect the relative fault of the Company and of the registered holder in
connection with such statements or omissions, as well as other equitable
considerations. The relative fault of the Company on the one hand and of the
registered holder hereof on the other shall be determined by reference to, among
other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to
information supplied by such party, and the parties' relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or
omission.

         The Company and the registered holder agree that it would not be just
and equitable if contribution pursuant to this Section 8 were determined by pro
rata allocation or by any other method of allocation that does not take account
of the equitable considerations referred to in the immediately preceding
paragraph. The amount paid or payable by an Indemnified Party as a result of the
Damages referred to in the immediately preceding paragraph shall be deemed to
include, subject to the limitations set forth above, any legal or other expenses
reasonably incurred by such Indemnified Party in connection with investigating
or defending any such action or claim. Notwithstanding the provisions of this
Section

                                       10

<PAGE>

8, the registered holder hereof shall in no event be required to contribute any
amount in excess of the amount by which the total price at which the Warrant
Shares of the registered holder were sold to the public (less underwriting
discounts and commissions) exceeds the amount of any damages which the
registered holder has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No Person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any Person who was not
guilty of such fraudulent misrepresentation.

         Section 9. Adjustment of Warrant Exercise Price. In order to prevent
dilution of the rights granted under this Warrant, the Warrant Exercise Price
shall be adjusted from time to time as follows:

         (a) Adjustment of Warrant Exercise Price upon Subdivision or
Combination of Common Stock. If the Company at any time after the date of
issuance of this Warrant, subdivides (by any stock split, stock dividend,
re-capitalization or otherwise) one or more classes of its outstanding shares of
Common Stock into a greater number of shares, the Warrant Exercise Price in
effect immediately prior to such subdivision will be proportionately reduced and
the number of shares of Common Stock obtainable upon exercise of this Warrant
will be proportionately increased. If the Company at any time after the date of
issuance of this Warrant combines (by combination, reverse stock split or
otherwise) one or more classes of its outstanding shares of Common Stock into a
smaller number of shares, the Warrant Exercise Price in effect immediately prior
to such combination will be proportionately increased and the number of shares
of Common Stock obtainable upon exercise of this Warrant will be proportionately
decreased.

         (b) Reorganization, Reclassification, Consolidation, Merger or Sale.
Any re-capitalization, reorganization reclassification, consolidation, merger,
sale of all or substantially all of the Company's assets to another Person or
other similar transaction which is effected in such a way that holders of Common
Stock are entitled to receive (either directly or upon subsequent liquidation)
stock, securities or assets with respect to or in exchange for Common Stock is
referred to herein as in "Organic Change." Prior to the consummation of any
Organic Change, the Company will make appropriate provision to insure that, upon
the consummation of such Organic Change, each of the holders of the Warrants
will thereafter have the right to acquire and receive in lieu of the Common
Stock, such shares of stock, securities or assets as may be issued or payable
with respect to or in exchange for the number of shares of Common Stock
immediately theretofore acquirable and receivable upon exercise of the Warrants
had such Organic Change not taken place. In any such case, the Company will make
appropriate provision with respect to such holders' rights and interests to
insure that the provisions of this Section 9(b) will thereafter be applicable to
the Warrants.

         (c) Notices.

                  (i) Immediately upon any adjustment of the Warrant Exercise
Price pursuant to this Section 9, the Company will give written notice thereof
to the holder of this Warrant, setting forth in reasonable detail and certifying
the calculation of such adjustment.

                  (ii) The Company will give written notice to the holder of
this Warrant at least twenty (20) days prior to the date on which the Company
closes its books or takes a record (A) with respect to any dividend or
distribution upon the Common Stock, (B) with respect to any pro rata
subscription offer

                                       11

<PAGE>

to holders of Common Stock or (C) for determining rights to vote with respect to
any Organic Change, dissolution or liquidation, except that in no event shall
such notice be provided to such holder prior to such information being made
known to the public.

                  (iii) The Company will also give written notice to the holder
of this Warrant at least twenty (20) days prior to the date on which any Organic
Change, dissolution or liquidation will take place.

         Section 10. Purchase Rights. If at any time the Company grants, issues
or sells any Options, Convertible Securities or rights to purchase stock,
warrants, securities or other property pro rata to the record holders of any
class of Common Stock (the "Purchase Rights"), then the holder of this Warrant
will be entitled to acquire, upon the terms applicable to such Purchase Rights,
the aggregate Purchase Rights which such holder could have acquired if such
holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant immediately before the date on which a record is taken
for the grant, issuance or sale of such Purchase Rights, or, if no such record
is taken, the date as of which the record holders of Common Stock are to be
determined for the grant, issue or sale of such Purchase Rights.

         Section 11. Lost, Stolen, Mutilated or Destroyed Warrant. If this
Warrant is lost, stolen, mutilated or destroyed, the Company shall, on receipt
of an indemnification undertaking, issue a new Warrant of like denomination and
tenor as the Warrant so lost, stolen, mutilated or destroyed.

         Section 12. Notice. Any notices, consents, waivers, or other
communications required or permitted to be given under the terms of this Warrant
must be in writing and will be deemed to have been delivered (i) upon receipt,
when delivered personally; (ii) upon receipt, when sent by facsimile, provided a
copy is mailed by U.S. certified mail, return receipt requested; (iii) three (3)
days after being sent by U.S. certified mail, return receipt requested; or (iv)
one (1) day after deposit with a nationally recognized overnight delivery
service, in each case properly addressed to the party to receive the same. The
addresses and facsimile numbers for such communications shall be:

          If to the Company:      JagNotes.com Inc.
                                  226 West 26th Street
                                  Studio D
                                  New York, NY 10001
                                  Attention: Stephen J. Schoepfer,
                                             Chief Operating Officer
                                  Telephone: (646) 205-8328
                                  Facsimile: (646) 205-8315

          With a copy to:         Morgan, Lewis and Bockius LLP
                                  101 Park Avenue
                                  New York, NY 10178
                                  Attention: W. Preston Tollinger, Esq.
                                             Kenneth Regensburg, Esq.
                                  Telephone: (212) 309-6000
                                  Facsimile: (212) 309-6273

                                       12

<PAGE>

         If to a holder of this Warrant, to it at the address set forth below
such holder's signature on the signature page hereof. Each party shall provide
five (5) days' prior written notice to the other party of any change in address
or facsimile number.

         Section 13. Amendments. This Warrant and any term hereof may be
changed, waived, discharged, or terminated only by an instrument in writing
signed by the Company or holder.

         Section 14. Date. The date of this Warrant is October 30, 2000. This
Warrant, in all events, shall be wholly void and of no effect after the close of
business on the Expiration Date, except that notwithstanding any other
provisions hereof, the provisions of Section 7 shall continue in full force and
effect after such date as to any Warrant Shares or other securities issued upon
the exercise of this Warrant.

         Section 15. Amendment and Waiver. Except as otherwise provided herein,
the provisions of this Warrant may be amended and the Company may take any
action herein prohibited, or omitted to perform any act herein required to be
performed by it, only if the Company has obtained the written consent of the
holder of this Warrant.

         Section 16. Descriptive Headings; Governing Law. The descriptive
headings of the several sections of this Warrant are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof. This
Warrant shall be governed by and interpreted under the laws of the State of New
York, without giving effect to any choice of law or conflict of law provision .

         This Warrant has been duly executed by the Company as of the date first
set forth above.

                                         JAGNOTES.COM  INC.

                                         By: /s/ Thomas J. Mazzarisi
                                             ----------------------------
                                             Name:  Thomas J. Mazzarisi
                                             Title: Executive Vice President and
                                                    General Counsel

CALP II LIMITED PARTNERSHIP

By:      _________________________________

Name:    _________________________________

Title:   _________________________________

Address: _________________________________

__________________________________________

__________________________________________

                                       13

<PAGE>

                                    EXHIBIT A

                              FORM OF SUBSCRIPTION

      (Complete and sign only exercise of the Warrant in whole or in part.)

TO:      JagNotes.com Inc.

         The undersigned, the holder of the attached Warrant to which this Form
of Subscription applies, hereby irrevocably elects to exercise the purchase
rights represented by such warrant for and to purchase thereunder _______ shares
of Common Stock, par value $0.00001 per share (the "Shares"), from JagNotes.com
Inc., (or such other securities issuable pursuant to the terms of the Warrant)
and either: (i) herewith makes payment of $_______ therefor in cash or by
certified or official bank check or (ii) elects to make payment upon a cashless
basis pursuant to Section 2 (a)(ii)(B) of the Warrant and hereby exercises
______ Warrants and the Average Market Price Per Share for purposes hereof is
$_______. The undersigned hereby requests that the certificate(s) representing
such securities be issued in the name(s) and delivered the address(es) as
follows:

Name:    ____________________________________________________________________

Address: ____________________________________________________________________

Social Security Number: _____________________________________________________

Deliver to:  ________________________________________________________________

Address:  ___________________________________________________________________

         This the foregoing subscription evidences an exercise of the Warrant to
purchase fewer than all of the Shares (or other securities issuable pursuant to
the terms of the Warrant) to which the undersigned is entitled under such
warrant, please issue a new warrant, of like tenor, relating to the remaining
portion of the securities issuable upon exercise of such warrant (or other
securities issuable pursuant to the terms of such warrant) in the name(s), and
deliver the same to the address(es), as follow:

Name:  ____________________________________________________________________

Address: __________________________________________________________________

Dated: ____________________________________________________________________

-----------------------------        ---------------------------------
(Name of Holder)                    (Social Security or Taxpayer Identification
                                    Number of Holder, if applicable)

-----------------------------
(Signature of Holder or Authorized
Signatory)

Signature Guaranteed:  __________________________________

                                       14

<PAGE>

                                    EXHIBIT B

                              FORM OF WARRANT POWER

         FOR VALUE RECEIVED, the undersigned does hereby assign and transfer to
____________________________________________ Federal Identification No.______, a
warrant to purchase shares of the capital stock of JagNotes.com Inc., a Nevada
corporation, represented by warrant certificate No._________, standing in the
name of the undersigned on the books of said corporation. The undersigned does
hereby irrevocably constitute and appoint ____________________________, attorney
to transfer the Warrants of said corporation, with full power of substitution in
the premises.

Dated: _______________________

                                          By: _________________________

                                          Its: _________________________

                                       15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00018-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00018-of-00352.parquet"}]]